Nuveen Asset Management, LLC - CARIBOU BIOSCIENCES INC ownership

CARIBOU BIOSCIENCES INC's ticker is and the CUSIP is 142038108. A total of 128 filers reported holding CARIBOU BIOSCIENCES INC in Q3 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.

Quarter-by-quarter ownership
Nuveen Asset Management, LLC ownership history of CARIBOU BIOSCIENCES INC
ValueSharesWeighting
Q3 2023$1,190,411
+20.3%
249,040
+6.9%
0.00%
Q2 2023$989,732
+63507.5%
232,878
-20.5%
0.00%
-100.0%
Q1 2023$1,556
-19.3%
292,964
-4.5%
0.00%0.0%
Q4 2022$1,927
-99.9%
306,886
+37.4%
0.00%0.0%
Q3 2022$2,357,000
+70.3%
223,407
-12.3%
0.00%0.0%
Q2 2022$1,384,000
-21.3%
254,866
+32.6%
0.00%0.0%
Q1 2022$1,758,000
+73.7%
192,180
+206.1%
0.00%
Q4 2021$1,012,000
-35.5%
62,781
-4.6%
0.00%
Q3 2021$1,570,00065,7880.00%
Other shareholders
CARIBOU BIOSCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 674,196$10,174,0006.39%
72 Investment Holdings, LLC 474,067$7,154,0006.35%
Velan Capital Investment Management LP 210,695$3,179,0002.47%
PFM Health Sciences, LP 4,092,309$59,418,0002.02%
Monashee Investment Management LLC 504,377$7,611,0001.88%
CloudAlpha Capital Management Limited/Hong Kong 415,000$6,262,0001.49%
Avidity Partners Management LP 2,674,067$40,352,0000.86%
Rokos Capital Management LLP 570,359$8,604,0000.52%
Green Alpha Advisors, LLC 35,592$537,0000.36%
Tekla Capital Management LLC 699,377$9,875,0000.32%
View complete list of CARIBOU BIOSCIENCES INC shareholders